Skip to content
healthcare.dev

Deflazacort Oral Suspension

NDC 81806-200, Deflazacort, suspension, from Doppel Farmaceutici S.r.l..

Product NDC
81806-200
Status
Listed
Labeler
Doppel Farmaceutici S.r.l.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220042
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81806-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFLAZACORT22.75 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
81806-200-73818060200731 BOTTLE in 1 CARTON (81806-200-73) / 13 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40a833a4-e029-a99e-e063-6394a90afd50

Use it

Look up 81806-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81806-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81806-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.